Accurate. Medical. Information.

Offering the best Isis Pharmaceuticals information online

Allegra OTC Categories
Allegra OTC Archives

Welcome! This is a non-profit site with user posted content about Isis Pharmaceuticals. We will soon be adding the ability for you to post your own blogs about Isis Pharmaceuticals, and start discussions about many related Isis Pharmaceuticals topics.




Important Disclaimer
This site is operated by an independent health information group. The blog content on this site is not reviewed by us, and we may not necessarily agree with the views presented by the writers. Please always follow the advice of your licensed health professional.

Implanted Sleep Device Shows Promising Early Results - Bio

{ Posted by Third Party Blog on 2010-05-17 16:08:26 }

(No summary provided, please click and read the full article.)

Top Small Cap Stocks with Highest Upside Potential Updated May 16 ...

{ Posted by Third Party Blog on 2010-05-16 20:56:03 }

99 ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) 66.7% 100 Chinacast Education Corporation (NASDAQ:CAST) 66.4% 101 Wonder Auto Technology, Inc. (NASDAQ:WATG) 66.4% 102 Lannett Company, Inc. (AMEX:LCI) 66.3% ...

Alnylam’s Scientific Founders

{ Posted by RNAi Litigation on 2010-05-13 13:39:00 }

(No summary provided, please click and read the full article.)

Isis Reports Financial Results and Highlights for First Quarter ...

{ Posted by Third Party Blog on 2010-05-13 12:26:39 }

Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended March 31, 2010. The Company finished the first quarter of 2010 with a pro forma net operating loss of $1.5 million compared to pro forma net ...

Now The Time To Buy Healthcare/Pharmaceutical Stocks? (May 13, 2010)

{ Posted by Third Party Blog on 2010-05-13 12:26:39 }

(No summary provided, please click and read the full article.)

Daily Business Report — May 10, 2010

{ Posted by Third Party Blog on 2010-05-13 12:26:39 }

Isis Pharmaceuticals has purchased property in the Carlsbad Oaks North Business Park for its new headquarters, which it will occupy after its existing lease expires in 2011. The property is 12.35 acres. The seller, Techbilt Construction ...

Report: Medical device companies lag in innovation | MassDevice ...

{ Posted by Third Party Blog on 2010-05-12 22:32:27 }

(No summary provided, please click and read the full article.)

Stock Picks For Thursday 13 May: Force Protection, Broadcom ...

{ Posted by Third Party Blog on 2010-05-12 22:32:27 }

ISIS - Isis Pharmaceutical AUXL - AUXILIUM PHARMACEUT ACXM - Acxiom Corporation SGEN - Seattle Genetics JAV - Intercontinental Te AIZ - ASSURANT INC CVBF - CVB Financial Corp ILMN - Illumina, Inc. GMO - General Moly Inc ...

Top U.S. Healthcare Stocks with Highest Upside Potential Updated ...

{ Posted by Third Party Blog on 2010-05-12 22:32:27 }

(No summary provided, please click and read the full article.)

A medical device industry innovation freefall

{ Posted by MedCity News on 2010-05-12 13:49:00 }

An index of the most innovative medical device and pharmaceutical companies shows that device makers fall short when it comes to developing next-generation technologies. Strategos, a division of consulting company Innovaro (NYSE:INV), collaborates with stock research firm wRatings Corp. to create a ...

Piper Jaffray Sees 25% Upside In ISIS Pharmaceuticals (ISIS) - Benzinga

{ Posted by admin on Thu, 02 Sep 2010 11:37:10 GMT+00:00 }


Piper Jaffray Sees 25% Upside In ISIS Pharmaceuticals (ISIS)
Benzinga
Piper Jaffray is being cautious on ISIS Pharmaceuticals (NASDAQ: ISIS) with a Neutral rating, despite seeing 25% upside in shares. ...
Isis: Liver enzymes up in 7 pct of mipomersen groupReuters
Genzyme says drug lowers cholesterolBoston Globe
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESCMarketWatch (press release)
StreetInsider.com (subscription) -RTT News
all 33 news articles »

Future of Genzyme / Isis Pharma's Cholesterol Drug Still Up in the Air - Seeking Alpha (blog)

{ Posted by admin on Fri, 03 Sep 2010 06:09:59 GMT+00:00 }


Future of Genzyme / Isis Pharma's Cholesterol Drug Still Up in the Air
Seeking Alpha (blog)
Few expected anything less than sterling phase III efficacy data for Genzyme (GENZ) and Isis Pharmaceuticals' (ISIS) cholesterol-lowering candidate, ...

Isis Pharma 2Q Loss Widens; Co Narrows 2010 Loss Estimate - Wall Street Journal

{ Posted by admin on Mon, 09 Aug 2010 11:32:04 GMT+00:00 }


Isis Pharma 2Q Loss Widens; Co Narrows 2010 Loss Estimate
Wall Street Journal
Isis Pharmaceuticals Inc.'s (ISIS) second-quarter loss widened more than analysts expected as the drug developer saw revenue fall while it continued to bump ...
Isis Pharmaceuticals, Inc. Q2 2010 Earnings Call TranscriptTheStreet.com
Isis takes larger 2Q loss on as spending risesBusinessWeek
Isis reports $25.2 million lossSan Diego Union Tribune
MarketWatch (press release) -Stock Markets Review -News-Medical.net
all 32 news articles »

Earnings Flashback: Since Reporting Quarterly Results 18 Days Ago Isis ... - Comtex Smartrend

{ Posted by admin on Sun, 29 Aug 2010 23:29:45 GMT+00:00 }


Earnings Flashback: Since Reporting Quarterly Results 18 Days Ago Isis ...
Comtex Smartrend
When Isis Pharmaceuticals (NASDAQ:ISIS) reported earnings 18 days ago on August 09, 2010, analysts, on average, expected the company to report ...
Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to ...PR Newswire (press release)
Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to ...Sacramento Bee

all 15 news articles »

Isis Pharmaceuticals: New 52-Week Low Set Today (ISIS) - Comtex Smartrend

{ Posted by admin on Tue, 24 Aug 2010 06:20:26 GMT+00:00 }


Isis Pharmaceuticals: New 52-Week Low Set Today (ISIS)
Comtex Smartrend
Shares of Isis Pharmaceuticals (NASDAQ:ISIS) traded at a new 52-week low yesterday of $7.76. Approximately 701000 shares have traded hands ...

and more »

Spectrum, Isis, Onyx and Amgen Seen as Picks - Barron's

{ Posted by admin on Tue, 24 Aug 2010 19:08:35 GMT+00:00 }


Spectrum, Isis, Onyx and Amgen Seen as Picks
Barron's
We believe large-cap stocks (Amgen, Celgene), technology stocks (ImmunoGen, Isis Pharmaceuticals (ISIS), Nektar), and momentum stocks (as listed above) will ...

and more »

Deal watch: Harnessing creative risk sharing - Nature.com

{ Posted by admin on Fri, 03 Sep 2010 12:31:29 GMT+00:00 }


Deal watch: Harnessing creative risk sharing
Nature.com
A key example is the recent deal between GlaxoSmithKline (GSK) and Isis Pharmaceuticals (31 March 2010) for the potential licensing of compounds originating ...

Cardiome Pharma shares up on EU approval. Inhibitex reports positive Phase1a ... - BioMedReports (subscription) (blog)

{ Posted by admin on Thu, 02 Sep 2010 00:23:06 GMT+00:00 }


Cardiome Pharma shares up on EU approval. Inhibitex reports positive Phase1a ...
BioMedReports (subscription) (blog)
(NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from the phase 3 study of mipomersen in patients with heterozygous familial ...

and more »

Isis Pharmaceuticals, Inc. Falls Short of Analyst Expectations; ISIS, NVO, CBST - Learning Markets

{ Posted by admin on Tue, 10 Aug 2010 09:19:29 GMT+00:00 }


Isis Pharmaceuticals, Inc. Falls Short of Analyst Expectations; ISIS, NVO, CBST
Learning Markets
Analysts were expecting Isis Pharmaceuticals, Inc. (ISIS) [Chart - Analysis - News] earnings to come in at ($0.15) per share for last quarter, but ISIS ...

and more »

Sanofi Ups The Pressure On Genzyme - Investopedia

{ Posted by admin on Wed, 01 Sep 2010 16:04:30 GMT+00:00 }


Sanofi Ups The Pressure On Genzyme
Investopedia
... the prospects for new drugs like Campath (Multiple Sclerosis) and Mipomersen, a cholesterol drug licensed in from Isis Pharmaceuticals (Nasdaq:ISIS). ...

and more »

Copyright 2010 © Syragon LLC www.allegraoverthecounter.com

All rights reserved.  Privacy Policy